Holen Sie sich die Stockscreener-App
10.26
4.48%
0.44
Handel nachbörslich:
10.26
Schlusskurs vom Vortag:
$9.82
Offen:
$9.76
24-Stunden-Volumen:
1.20M
Relative Volume:
1.06
Marktkapitalisierung:
$818.27M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+12.01%
1M Leistung:
-9.20%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$9.65
$10.37
1-Wochen-Bereich:
$8.98
$11.29
52-Wochen-Spanne:
$5.33
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
Firmenname
Niagen Bioscience Inc
Sektor
Branche
Telefon
310-388-6706
Adresse
10900 WILSHIRE BLVD, LOS ANGELES
Vergleichen Sie NAGE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
10.26 | 783.17M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-08-16 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-08-11 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | Eingeleitet | ROTH Capital | Buy |
| 2019-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2019-02-14 | Eingeleitet | B. Riley FBR | Buy |
| 2017-11-27 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-09-25 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-01-03 | Eingeleitet | Rodman & Renshaw | Buy |
Alle ansehen
Niagen Bioscience Inc Aktie (NAGE) Neueste Nachrichten
Niagen Bioscience (NASDAQ:NAGE) Given New $12.00 Price Target at HC Wainwright - MarketBeat
Q2 EPS Forecast for Niagen Bioscience Increased by Analyst - MarketBeat
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives $13.22 Average PT from Brokerages - MarketBeat
Niagen Bioscience stock price target raised to $12 from $11 at H.C. Wainwright - Investing.com Canada
Real time scanner hits for Niagen Bioscience Inc. explainedRisk Balanced Picks for Safer Trading - Newser
Niagen Bioscience Reports Strong Q2 Growth and Outlook - TipRanks
Is Niagen Bioscience Inc. a defensive stockFree Investment Webinars - classian.co.kr
News impact scoring models applied to Niagen Bioscience Inc.In-Depth Stock Trading Volume Analysis - Newser
Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Earnings Beat - MarketBeat
Niagen Bioscience Shares Climb Following Exclusive License for Parkinson’s Therapy - MSN
Roth Capital Cuts Earnings Estimates for Niagen Bioscience - MarketBeat
Risk adjusted return profile for Niagen Bioscience Inc. analyzedSafe and Scalable Return Strategy Blueprint - Newser
Can Niagen Bioscience Inc. rally from current levelsLow Risk Strategy with Smart Entry Zones - Newser
Will a bounce in Niagen Bioscience Inc. offer an exitProven Trading System with Consistent Gains - Newser
Niagen Bioscience, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st
Earnings Beat: Niagen Bioscience, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Niagen Bioscience, Inc. (NASDAQ:NAGE) Given Average Recommendation of “Buy” by Brokerages - Defense World
Niagen Bioscience (NASDAQ:NAGE) Shares Gap Up Following Better-Than-Expected Earnings - Defense World
Should you wait for a breakout in Niagen Bioscience Inc.Free Fundamental Growth Stock Analysis - Newser
Niagen Bioscience Reports Strong Q2 Sales Growth - The Globe and Mail
Niagen Bioscience: Q2 Earnings Snapshot - New Haven Register
Niagen Bioscience (NASDAQ:NAGE) Cut to Buy at Wall Street Zen - MarketBeat
Niagen Bioscience shares rise 21.91% premarket after Q2 sales beat estimates. - AInvest
Earnings call transcript: Niagen Bioscience Q2 2025 earnings beat expectations - Investing.com
Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook - BioSpace
Niagen NAGE Q2 2025 Earnings Call Transcript - Mitrade
Niagen Bioscience shares rise 24.88% after-hours after Q2 sales beat estimates. - AInvest
Niagen Bioscience (NAGE) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
Transcript : Niagen Bioscience, Inc., Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
Niagen Bioscience Q2 2025 presentation: Revenue jumps 37%, ingredient sales surge 135% - Investing.com Nigeria
Niagen Bioscience Q2 2025 presentation: Revenue jumps 37%, ingredient sales surge 135% By Investing.com - Investing.com South Africa
Niagen Bioscience earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Niagen Bioscience Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Press Release: Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook - 富途牛牛
What You Can Learn From Niagen Bioscience, Inc.'s (NASDAQ:NAGE) P/S After Its 28% Share Price Crash - simplywall.st
Niagen Bioscience shares fall 3.53% premarket ahead of CEO's participation in Canaccord Genuity's 45th Annual Growth Conference. - AInvest
Niagen Bioscience Inc expected to post earnings of 1 cent a shareEarnings Preview - TradingView
Niagen Bioscience to Present at Canaccord Genuity’s 45th Annual Growth Conference - BioSpace
Niagen Bioscience (NASDAQ:NAGE) Stock Rating Lowered by Wall Street Zen - Defense World
Niagen Bioscience to Present at Canaccord Genuity's 45th Annual Growth Conference - Lelezard
What is the dividend policy of Niagen Bioscience Inc. stockDiscover high-impact investment opportunities - Jammu Links News
What makes Niagen Bioscience Inc. stock price move sharplyTrend Reversal Watch with Entry Signals - Newser
Should I hold or sell Niagen Bioscience Inc. stock in 2025Get daily expert analysis on top stocks - Jammu Links News
What is Niagen Bioscience Inc. company’s growth strategyGet exclusive access to professional stock picks - Jammu Links News
Is Niagen Bioscience Inc. a growth stock or a value stockFree Predictions - Jammu Links News
Why is Niagen Bioscience Inc. stock attracting strong analyst attentionSuperior risk-adjusted returns - Jammu Links News
What are analysts’ price targets for Niagen Bioscience Inc. in the next 12 monthsHigh-profit stock alerts - Jammu Links News
How strong is Niagen Bioscience Inc. company’s balance sheetDiscover high-impact stocks for your portfolio - Jammu Links News
When is Niagen Bioscience Inc. stock expected to show significant growthUnlock powerful trading alerts for success - Jammu Links News
Niagen Bioscience (NASDAQ:NAGE) Shares Up 6%Here's Why - MarketBeat
Finanzdaten der Niagen Bioscience Inc-Aktie (NAGE)
Es liegen keine Finanzdaten für Niagen Bioscience Inc (NAGE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Niagen Bioscience Inc-Aktie (NAGE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lopez Carlos Luis | SVP, General Counsel |
Mar 07 '25 |
Buy |
7.86 |
273 |
2,146 |
2,251 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Option Exercise |
3.66 |
50,001 |
183,004 |
281,340 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Sale |
6.19 |
37,161 |
229,956 |
244,179 |
0.91%
3.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):